| Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of … MW Bekkenk, FAMJ Geelen, PCV Vader, F Heule, ML Geerts, ... Blood, The Journal of the American Society of Hematology 95 (12), 3653-3661, 2000 | 954 | 2000 |
| Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study F Grange, MW Bekkenk, J Wechsler, C Meijer, L Cerroni, M Bernengo, ... Journal of clinical oncology 19 (16), 3602-3610, 2001 | 315 | 2001 |
| CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature MW Bekkenk, PM Jansen, CJLM Meijer, R Willemze Annals of oncology 15 (7), 1097-1108, 2004 | 300 | 2004 |
| Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients MW Bekkenk, MH Vermeer, PM Jansen, AMW van Marion, ... Blood 102 (6), 2213-2219, 2003 | 274 | 2003 |
| Clinical staging and prognostic factors in folliculotropic mycosis fungoides S Van Santen, REJ Roach, R van Doorn, B Horváth, MS Bruijn, ... JAMA dermatology 152 (9), 992-1000, 2016 | 153 | 2016 |
| CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior MH Vermeer, R van Doorn, D Dukers, MW Bekkenk, CJLM Meijer, ... Journal of clinical oncology 19 (23), 4322-4329, 2001 | 142 | 2001 |
| CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer C Assaf, S Gellrich, S Whittaker, A Robson, L Cerroni, C Massone, H Kerl, ... Journal of clinical pathology 60 (9), 981-989, 2007 | 133 | 2007 |
| Development and validation of the Vitiligo Extent Score (VES): an international collaborative initiative N van Geel, J Lommerts, M Bekkenk, A Wolkerstorfer, CAC Prinsen, ... Journal of Investigative Dermatology 136 (5), 978-984, 2016 | 127 | 2016 |
| Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients MW Bekkenk, MH Vermeer, ML Geerts, EM Noordijk, F Heule, ... Journal of clinical oncology 17 (8), 2471-2471, 1999 | 112 | 1999 |
| Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study L Wieske, KPJ van Dam, M Steenhuis, EW Stalman, LYL Kummer, ... The Lancet Rheumatology 4 (5), e338-e350, 2022 | 111 | 2022 |
| Primary and secondary cutaneous CD30-positive lymphoproliferative disorders: long term follow-up data of 219 patients and guidelines for diagnosis and treatment. A report from … M Bekkenk, F Geelen, PC van Voorst Vader, F Heule, ML Geerts, ... Blood 95 (12), 3653-3661, 2000 | 62 | 2000 |
| Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group S Van Santen, R van Doorn, KJ Neelis, LA Daniëls, B Horváth, MS Bruijn, ... British Journal of Dermatology 177 (1), 223-228, 2017 | 55 | 2017 |
| Breakthrough SARS-CoV-2 infections with the delta (B. 1.617. 2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy … L Boekel, EW Stalman, L Wieske, F Hooijberg, KPJ van Dam, YR Besten, ... The Lancet Rheumatology 4 (6), e417-e429, 2022 | 53 | 2022 |
| Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma DJ Kadouch, MM Leeflang, YS Elshot, C Longo, M Ulrich, AC van der Wal, ... Journal of the European Academy of Dermatology and Venereology 31 (10), 1641 …, 2017 | 52 | 2017 |
| Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 J Fang, J Jia, M Makowski, M Xu, Z Wang, T Zhang, JW Hoskins, J Choi, ... Nature communications 8 (1), 15034, 2017 | 48 | 2017 |
| Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference EY Gan, V Eleftheriadou, S Esmat, I Hamzavi, T Passeron, M Böhm, ... Pigment cell & melanoma research 30 (1), 28-40, 2017 | 48 | 2017 |
| Finding consensus after two decades of breast implant-associated anaplastic large cell lymphoma MW Clemens, RC DeCoster, B Fairchild, AA Bessonov, FS Di Pompeo Seminars in Plastic Surgery 33 (04), 270-278, 2019 | 47 | 2019 |
| EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate MW Bekkenk, MH Vermeer, CJLM Meijer, PM Jansen, JM Middeldorp, ... Blood 102 (12), 4243-4243, 2003 | 47 | 2003 |
| Development and validation of a patient-reported outcome measure in vitiligo: the Self Assessment Vitiligo Extent Score (SA-VES) N van Geel, JE Lommerts, MW Bekkenk, CAC Prinsen, V Eleftheriadou, ... Journal of the American Academy of Dermatology 76 (3), 464-471, 2017 | 46 | 2017 |
| Lymphomatoid papulosis with a natural killer‐cell phenotype MW Bekkenk, PM Kluin, PM Jansen, CJLM Meijer, R Willemze British journal of dermatology 145 (2), 318-322, 2001 | 40 | 2001 |
